Klinische Forschung Karlsruhe GmbH

At Klinische Forschung Karlsruhe GmbH, clinical trials in cardiovascular diseases and nutritional and metabolic diseases focus on conditions such as atherosclerotic cardiovascular disease, hyperlipidemia, elevated Lp(a), uncontrolled hypertension, and obesity. These studies are designed to test new treatments and assess whether they can reduce risk and improve long-term heart and metabolic health.

• Testing therapies aimed at lowering cardiovascular risk, including major heart and vascular events
• Evaluating treatments for high cholesterol, elevated lipoprotein(a), and resistant hypertension
• Studying weight management approaches for people with obesity and related cardiometabolic conditions

The site’s work in this area brings together prevention-focused research and treatment studies for common risk factors that contribute to serious cardiovascular disease.

Research at this site also covers musculoskeletal diseases and nervous system diseases, with trials in osteoarthritis, chronic low back pain, diabetic peripheral neuropathic pain, and related pain conditions. The main goal is to evaluate new ways to relieve persistent pain and improve daily function for people living with long-term joint or nerve-related problems.

• Assessing pain relief options for knee osteoarthritis and chronic non-specific low back pain
• Investigating treatments for diabetic nerve pain and other difficult-to-manage pain syndromes
• Exploring therapies that may improve comfort, mobility, and quality of life

This is a strong area of clinical research at Klinische Forschung Karlsruhe GmbH, especially for conditions where standard pain treatment has not been enough.

The portfolio includes digestive system diseases, immune system diseases, and hemic and lymphatic diseases, with studies in irritable bowel syndrome, gout with hyperuricemia, and chronic lymphocytic leukemia/small lymphocytic lymphoma. These trials aim to improve symptom control, support disease management, and evaluate whether new or alternative treatments work better than current options.

• Testing therapies for IBS, including diarrhea-predominant and mixed forms
• Evaluating treatments for gout and elevated uric acid levels
• Studying new approaches for blood cancer care in CLL/SLL

This research reflects a broad interest in both chronic gastrointestinal symptoms and more specialized immune and blood-related conditions.

Trials in respiratory tract diseases and virus diseases include work on influenza, refractory chronic cough, and chronic obstructive pulmonary disease. The research is centered on improving prevention and symptom control, while also examining the safety and effectiveness of vaccine and treatment options for common respiratory illnesses.

• Evaluating influenza vaccine performance and immune response in older adults
• Studying new treatments for persistent or unexplained chronic cough
• Exploring therapies for chronic lung disease and related respiratory symptoms

These studies highlight the site’s role in both infectious disease prevention and the management of ongoing respiratory conditions.

Additional trials address mental disorders, skin and connective tissue diseases, and female urogenital diseases and pregnancy complications. Key topics include major depressive disorder, insomnia disorder, female androgenetic alopecia, and primary dysmenorrhea, with the aim of improving symptom relief and everyday well-being through better treatment options.

• Testing treatments for depression and sleep problems
• Evaluating hair loss therapies in women with hormone-related hair thinning
• Studying relief options for menstrual pain and related discomfort

Together, these studies show a diverse research profile that extends beyond internal medicine into mental health, dermatology, and women’s health.